Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials
Amirhossein Sahebkar(Mashhad University of Medical Sciences), Maciej Banach(John Paul II Catholic University of Lublin), Gregory Y.H. Lip(Medical University of Białystok), Manfredi Rizzo(University of Palermo), Ian Graham(Ottawa Hospital), Jacek Rysz(Medical University of Lodz), Paul Muntner(University of North Carolina at Chapel Hill), Nathan D. Wong(University of California San Diego), Laurence Sperling(Emory University), Dimitri P. Mikhailidis(University College Hospital), Sorin Ursoniu(Victor Babeș University of Medicine and Pharmacy Timișoara)
Cited by 175
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k